115 related articles for article (PubMed ID: 34472305)
1. [Optimizations of an ELISA-like high-throughput screening assay for the discovery of β-catenin/TCF4 interaction antagonists].
Fu Z; Yan G; Zhu X; Liu X; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2878-2889. PubMed ID: 34472305
[TBL] [Abstract][Full Text] [Related]
2. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
Chen Y; Fu Z; Li D; Yue Y; Liu X
Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
[TBL] [Abstract][Full Text] [Related]
3. [Development of an ELISA-based high throughput screening method for novel anticancer agents targeting β-catenin/Lef1 interaction].
Chen Y; Niu X; Li Y; Liu X
Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):707-717. PubMed ID: 31001956
[TBL] [Abstract][Full Text] [Related]
4. A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.
Shin SH; Lim DY; Reddy K; Malakhova M; Liu F; Wang T; Song M; Chen H; Bae KB; Ryu J; Liu K; Lee MH; Bode AM; Dong Z
EBioMedicine; 2017 Nov; 25():22-31. PubMed ID: 29033371
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway.
Zheng HE; Wang G; Song J; Liu Y; Li YM; Du WP
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7750-7759. PubMed ID: 30536319
[TBL] [Abstract][Full Text] [Related]
6. Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression.
Wang N; Huo R; Cai B; Lu Y; Ye B; Li X; Li F; Xu H
Free Radic Biol Med; 2016 Jul; 96():34-44. PubMed ID: 27068063
[TBL] [Abstract][Full Text] [Related]
7. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor 4 expression and correlation with tumor progression in gallbladder cancer.
Neogi K; Tewari M; Singh AK; Sharma K; Tej GNVC; Verma SS; Gupta SC; Nayak PK
J Cancer Res Ther; 2022; 18(3):668-676. PubMed ID: 35900539
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway.
Neogi K; Murumkar PR; Sharma P; Yadav P; Tewari M; Karunagaran D; Nayak PK; Yadav MR
Transl Oncol; 2022 May; 19():101395. PubMed ID: 35325837
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel fluorescence polarization-based assay for studying the β-catenin/Tcf4 interaction.
Tian W; Xu Y; Han X; Duggineni S; Han X; Huang Z; An J
J Biomol Screen; 2012 Apr; 17(4):530-4. PubMed ID: 22127421
[TBL] [Abstract][Full Text] [Related]
12. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
14. p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin·TCF4 Interaction.
Wu Y; Zhang Y; Zhang H; Yang X; Wang Y; Ren F; Liu H; Zhai Y; Jia B; Yu J; Chang Z
J Biol Chem; 2010 Nov; 285(45):34621-31. PubMed ID: 20739273
[TBL] [Abstract][Full Text] [Related]
15. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo.
Sun Y; Wang P; Zhang Q; Wu H
J Gene Med; 2022 Feb; 24(2):e3343. PubMed ID: 33871149
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
17. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
[TBL] [Abstract][Full Text] [Related]
18. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
19. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
20. The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1.
Zhu X; Yuan C; Tian C; Li C; Nie F; Song X; Zeng R; Wu D; Hao X; Li L
J Biol Chem; 2018 Apr; 293(14):5335-5344. PubMed ID: 29462785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
